Latest from Scidentify

Explore platform improvements, research partnerships, and milestones driving innovation in immune data analysis.
09.06.2026

LIH presents poster at CYTO 2026 using SCIDENTIFY solution

”Doubling of the capacity of mass cytometry by means of doublet recovery. A study of 1500 human samples at the Luxembourg institute of health”
09.06.2026

SCIDENTIFY presents poster at CYTO 2026

”Increasing the Throughput of Mass Cytometry 4X Without Cell Loss by Recovery of Singlet Events from Doublet Contamination”
07.06.2026

SCIDENTIFY booth at CYTO 2026

SCIDENTIFY welcomes KOLs and collaborators at West Palm Beach, FL for the Annual Meeting of the International Society for Advancement of Cytometry (ISAC)
28.04.2026

SCIDENTIFY presents at French Mass Cytometry User Forum

”Increasing the Throughput of Mass Cytometry 4X Without Cell Loss by Recovery of Singlet Events from Doublet Contamination”
30.03.2026

SCIDENTIFY reaches first milestone LIH

First 300/1500 human specimens processed of the clinical study conducted together with the National Cytometry Platform of the Luxembourg Institute of Health.
23.02.2026

SCIDENTIFY has abstract accepted CYTO2026

”Increasing the Throughput of Mass Cytometry 4x Without Cell Loss by Recovery of Singlet Events from Doublet Contamination”
07.10.2025

SCIDENTIFY has abstract accepted SITC

”A first-in-class multiplexed high-dimensional mass cytometry platform to determine immune effector–tumor binding and cytotoxicity in antibody and cellular immunotherapy studies”
23.09.2025

SCIDENTIFY becomes offical supplier Science Exchange

Compliant supply, predictible turn-around and transparent pricing.
15.07.2025

SCIDENTIFY launches Structify as data processing hub

Streamline your interaction with SCIDENTIFY through our new webapp, safe, secure, fast.
08.06.2025

SCIDENTIFY launches Doublet RecoveryTM for high-througput mass cytometry

Increase your event rates with 2.5X without loss of resolution
03.06.2025

SCIDENTIFY presents own research at CYTO 2025 validating SwissBeadsTM for batch experiments with DRFZ

Marker variability reduced up to 3X compared to competitor product
01.04.2025

SCIDENTIFY launches SwissBeadsTM for quantified mass cytometry

Reduce run-to-run variability and obtain antibody copy numbers directly as output

Scidentify's Doublet Recovery pipeline has doubled the capacity of our CyTOF XT. We are convinced the tech can increase the throughput further and plan to TRIPLE the device throughput by Q1 2027  

ANTONIO COSMA,
HDR, PHD
Head of National Cytometry Platform, Integrated Biobank of Luxembroug, Luxembourg Institute of Health

We use SCIDENTIFY tech to develop internal standards for our state-of-the-art optical process. Their ability to access information in the ion cloud is unprecedented.

Prof. Dr. Sara Skrabalak
Director CSENND, Indiana University, Bloomington | Editor-in-Chief, Chemistry of Materials

SCIDENTIFYs morphological parameters enhance the accuracy of downstream clustering algorithms.

Dr. Christoph SCHwärzler
Mass cytometry specialist, EPFL | Ex-Novartis

We use SCIDENTIFY services to improve our fluorescent nanoparticle product-line. They have provided us such a deep-understanding of our system. Amazing!

Lars dähne
CEO, Surflay Nanotec GmbH
Unlock the full potential of your
mass cytometer in a single app
Book Demo
We respect your privacy. Please contact us at sales@scidentify.com for information on how we handle data.
Copyright © 2025. Scidentify. All rights reserved. All products are intended for research use only.